Light therapy in bulimia nervosa: a double-blind, placebo-controlled study

Area of Science:

• Psychiatry
• Clinical Psychology
• Neuroscience

Background:

• Bulimia nervosa (BN) is an eating disorder often accompanied by affective disturbances.
• Light therapy is a recognized treatment for seasonal affective disorder (SAD) and has shown potential for other mood disorders.

Purpose of the Study:

• To investigate the efficacy of bright light therapy in alleviating affective symptoms and reducing food intake in individuals with bulimia nervosa.
• To examine the impact of light therapy on binge-eating episodes in BN patients.

Main Methods:

• A double-blind, placebo-controlled study involving 18 women diagnosed with BN.
• Participants received either bright light (2500 lux) or dim light (placebo) daily for one week.
• Mood and bulimic symptoms were assessed using the SIGH-SAD, BDI, Bulimic Symptoms Checklist, Profile of Mood States, and Daily Binge Record.

Main Results:

• Bright light exposure led to significant improvements in depressed mood, as measured by the BDI and SIGH-SAD.
• Depression levels returned to pretreatment levels after light therapy withdrawal.
• No significant effects of light therapy were observed on the frequency, size, or content of binge-eating episodes.
• The placebo group did not show any changes in depression.

Conclusions:

• Bright light therapy may be a useful adjunctive treatment for improving mood symptoms in individuals with bulimia nervosa.
• Light therapy's effects on mood appear transient and dependent on continued exposure.
• Further research is needed to explore the mechanisms underlying the relationship between light, mood, and eating behaviors in BN.